To Explore the Pharmacokinetics and Relative Bioavailability of Sulfatinib Capsules in Two Different Manufacturers in Chinese Adult Male Healthy Volunteers

Trial Profile

To Explore the Pharmacokinetics and Relative Bioavailability of Sulfatinib Capsules in Two Different Manufacturers in Chinese Adult Male Healthy Volunteers

Not yet recruiting
Phase of Trial: Phase I

Latest Information Update: 02 Apr 2018

At a glance

  • Drugs Sulfatinib (Primary)
  • Indications Biliary cancer; Neuroendocrine tumours; Solid tumours; Thyroid cancer
  • Focus Pharmacokinetics
  • Sponsors Hutchison MediPharma
  • Most Recent Events

    • 02 Apr 2018 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top